![event guide cover event guide cover](https://dermatology-drugdevelopment-europe.com/wp-content/uploads/sites/42/2024/04/event-guide-cover.png)
Having trouble downloading the brochure?
Let us know and we’ll email it to you instead.
With a 3-day agenda to explore, featuring 20+ expert speakers, 2 deep-dive workshops covering the latest in JAK inhibitors and clinical stratification, recruitment and endpoint strategies, thought-provoking panels on the future of inflammatory-drug development and unmissable interactive sessions to plan your market access strategy, download your copy to:
1.
Learn who was leading research in the shared and unique characteristics of AD, PN & CSU
2.
Discover how clinical programs are revealing novel disease targets
3.
Uncover technologies making biomarker-driven drug development a reality
4.
Find out which candidates are progressing to the clinic and tactics bridging the translational gap
5.
Get updates on clinical pipelines making headway towards improving long-term patient QoL
From topical to systemic and small molecule to biologic, get your copy to discover how Sanofi, Nektar Therapeutics, Affibody, Moonlake Therapeutics & more are shaping today’s dermatology drug development landscape and integrate learnings to expedite your route to market!
Who Will You Hear From?
![49392- web banner long (3) 49392- web banner long (3)](https://dermatology-drugdevelopment-europe.com/wp-content/uploads/sites/42/2023/11/49392-web-banner-long-3.png)
“Good presentations and interesting new technologies from EU Biotech”
Kim Kjøller, Chief Executive Officer, Union Therapeutics